Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Princess Máxima Center for Pediatric Oncology

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Princess Máxima Center for Pediatric Oncology is the largest pediatric cancer center in Europe. Opened in May 2018, this specialized research hospital completely centralized all highly complex childhood cancer care, research, and training in the Netherlands under one roof. Driven by a mission to achieve a 100% cure rate while maintaining an optimal quality of life, the center operates across four distinct departments: Hemato-Oncology, Solid Tumors, Neuro-Oncology, and Quality-of-Life.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Children's hospital

Business Subcategory

Source: Human-provided. Children's hospital
Source: Human-provided. Research institute
Source: Trial-derived.
26Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
8Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
48Unique Conditions
Source: Trial-derived.
71Unique Sponsors

Conditions

Source: Trial-derived. Acute Lymphoblastic Leukemia (ALL) (2)Source: Trial-derived. Adrenoleukodystrophy (ALD) (2)Source: Trial-derived. Cerebral Adrenoleukodystrophy (CALD) (2)Source: Trial-derived. Neuroblastoma (2)Source: Trial-derived. X-Linked Adrenoleukodystrophy (X-ALD) (2)Source: Trial-derived. Acute Myeloid Leukemia (1)Source: Trial-derived. Acute Myeloid Leukemia (AML) (1)Source: Trial-derived. ALK-positive Histiocytosis (1)

Sponsors

Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (3)Source: Trial-derived. Australian & New Zealand Children's Haematology/Oncology Group (2)Source: Trial-derived. Centre Hospitalier Universitaire de Nice (2)Source: Trial-derived. Charite University, Berlin, Germany (2)Source: Trial-derived. Children's Oncology Group (2)Source: Trial-derived. Deutsche Krebshilfe e.V., Bonn (Germany) (2)Source: Trial-derived. Genetix Biotherapeutics Inc. (2)Source: Trial-derived. Gustave Roussy, Cancer Campus, Grand Paris (2)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot